DocuSign (NASDAQ: DOCU) was one of the best-positioned companies to benefit from the pandemic. The company's e-signature platform boomed as industries that had resisted the technology had little ...

Docusign is a compelling 'growth at a reasonable price' play, benefiting from a strong Q2 beat, raised guidance, and improving sales execution. The company’s turnaround is evident in rebounding ...